CILITAC 0.25 mg contains Tacrolimus, a low-dose immunosuppressant used to help prevent organ transplant rejection. This strength is typically used for fine dose adjustments to maintain stable immunosuppression.
Composition
Tacrolimus Capsule IP – 0.25 mg
Uses
Low-dose immunosuppression in transplant recipients
Dose titration to maintain optimal Tacrolimus levels
Benefits
Helps prevent rejection of transplanted organs
Allows precise dose control
Supports long-term graft stability
Use only under guidance of a transplant specialist or healthcare professional.
